Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?

被引:15
|
作者
Abas, Abdul Hawil [1 ]
Marfuah, Siti [1 ]
Idroes, Rinaldi [2 ]
Kusumawaty, Diah [3 ]
Fatimawali [4 ]
Park, Moon Nyeo [5 ]
Siyadatpanah, Abolghasem [6 ]
Alhumaydhi, Fahad A. [7 ]
Mahmud, Shafi [8 ]
Tallei, Trina Ekawati [1 ]
Bin Emran, Talha [9 ]
Kim, Bonglee [5 ]
机构
[1] Sam Ratulangi Univ, Fac Math & Nat Sci, Dept Biol, Manado 95115, North Sulawesi, Indonesia
[2] Univ Syiah Kuala, Fac Math & Nat Sci, Dept Pharm, Banda Aceh 23111, Aceh, Indonesia
[3] Univ Pendidikan Indonesia, Fac Math & Nat Sci Educ, Dept Biol, Bandung 40154, West Java, Indonesia
[4] Sam Ratulangi Univ, Fac Math & Nat Sci, Pharm Study Program, Manado 95115, North Sulawesi, Indonesia
[5] Kyung Hee Univ, Coll Korean Med, Seoul 05253, South Korea
[6] Birjand Univ Med Sci, Ferdows Sch Paramed & Hlth, Birjand 9717853577, Iran
[7] Qassim Univ, Coll Appl Med Sci, Dept Med Labs, Buraydah 52571, Saudi Arabia
[8] Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Sci, Canberra, ACT 0200, Australia
[9] BGC Trust Univ Bangladesh, Dept Pharm, Chittagong 4381, Bangladesh
来源
MOLECULES | 2022年 / 27卷 / 07期
基金
新加坡国家研究基金会;
关键词
COVID-19; SARS-CoV-2; Omicron; natural immunity; hybrid immunity; MAIN PROTEASE; TRANSMISSION; MECHANISMS; INFECTION; VACCINES; FUTURE; ORIGIN;
D O I
10.3390/molecules27072221
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The coronavirus disease 2019 (COVID-19) pandemic is still ongoing, with no signs of abatement in sight. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of this pandemic and has claimed over 5 million lives, is still mutating, resulting in numerous variants. One of the newest variants is Omicron, which shows an increase in its transmissibility, but also reportedly reduces hospitalization rates and shows milder symptoms, such as in those who have been vaccinated. As a result, many believe that Omicron provides a natural vaccination, which is the first step toward ending the COVID-19 pandemic. Based on published research and scientific evidence, we review and discuss how the end of this pandemic is predicted to occur as a result of Omicron variants being surpassed in the community. In light of the findings of our research, we believe that it is most likely true that the Omicron variant is a natural way of vaccinating the masses and slowing the spread of this deadly pandemic. While the mutation that causes the Omicron variant is encouraging, subsequent mutations do not guarantee that the disease it causes will be less severe. As the virus continues to evolve, humans must constantly adapt by increasing their immunity through vaccination.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] COVID-19: Omicron - the latest, the least virulent, but probably not the last variant of concern of SARS-CoV-2
    Bruessow, Harald
    MICROBIAL BIOTECHNOLOGY, 2022, 15 (07): : 1927 - 1939
  • [32] Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19
    Can-rong Wu
    Wan-chao Yin
    Yi Jiang
    H. Eric Xu
    Acta Pharmacologica Sinica, 2022, 43 : 3021 - 3033
  • [33] COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects
    Zarebska-Michaluk, Dorota
    Hu, Chenlin
    Brzdek, Michal
    Flisiak, Robert
    Rzymski, Piotr
    VACCINES, 2022, 10 (08)
  • [34] Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity
    Joung, Sandy Y.
    Ebinger, Joseph E.
    Sun, Nancy
    Liu, Yunxian
    Wu, Min
    Tang, Amber B.
    Prostko, John C.
    Frias, Edwin C.
    Stewart, James L.
    Sobhani, Kimia
    Cheng, Susan
    JAMA NETWORK OPEN, 2022, 5 (08) : E2227241
  • [35] COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer
    Zeng, Cong
    Evans, John P.
    Chakravarthy, Karthik
    Qu, Panke
    Reisinger, Sarah
    Song, No-Joon
    Rubinstein, Mark P.
    Shields, Peter G.
    Li, Zihai
    Liu, Shan-Lu
    CANCER CELL, 2022, 40 (02) : 117 - 119
  • [36] COVID-19 Reinfection in a Healthcare Worker; Is There a Definitive Immunity Against SARS-CoV-2?
    Ahmadi, Sayyed Reza
    Ardakani, Saeideh Anvari
    Kalani, Navid
    Habibzadeh, Seyed Reza
    Moradi, Elnaz Vafadar
    Foroughian, Mahdi
    FRONTIERS IN EMERGENCY MEDICINE, 2021, 5 (02):
  • [37] Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant
    Chemaitelly, Hiam
    Bertollini, Roberto
    Abu-Raddad, Laith J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (27): : 2585 - 2586
  • [38] COVID-19 vaccination induces humoral and cellular immunity to SARS-CoV-2 with cross-recognition of the Omicron variant and IgA secretion
    Ruhl, L.
    Kuehne, J. F.
    Beushausen, K.
    Keil, J.
    Christoph, S.
    Sauer, J.
    Falk, C. S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 167 - 168
  • [39] Symptoms can predict COVID-19 pneumonia in patients infected with SARS-CoV-2 Omicron variants
    Liao, Qian-Qian
    Zhu, Ze-Feng
    Zhu, Ke-Wei
    Yang, Zhe
    Liu, Gui-Li
    Li, Xiang-Qing
    Ge, Run
    Xu, Hong-Zhen
    Jiang, Xuan
    Tang, Yan-Feng
    Chen, Yan
    Yu, Zhi-Ling
    Liao, Zeng-Zhen
    Huang, Shao-Yuan
    Qiu, Yue
    Zhao, Bin-Jing
    Fu, Yong-Fei
    Qin, Dong
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [40] Effect of Previous COVID-19 Vaccination on Humoral Immunity 3 Months after SARS-CoV-2 Omicron Infection and Booster Effect of a Fourth COVID-19 Vaccination 2 Months after SARS-CoV-2 Omicron Infection
    Kim, Jinsoo
    Seo, Hyeonji
    Kim, Han-Wool
    Kim, Dongbum
    Kwon, Hyung-Joo
    Kim, Yong-Kyun
    VIRUSES-BASEL, 2022, 14 (11):